Financhill
Back

KBC Groupe NV Vs. Viking Therapeutics Industry Stock Comparison

Sell
33

KBCSY
KBC Groupe NV

Last Price:
35.25
Seasonality Move:
-0.38%
Sell
40

VKTX
Viking Therapeutics

Last Price:
52.02
Seasonality Move:
-3.31%
Sell
33
KBC Groupe NV (KBCSY) is a Sell

Is KBC Groupe NV a Buy, Sell or Hold?

  • The current KBC Groupe NV [KBCSY] share price is $35.25. The Score for KBCSY is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • KBCSY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $52.02. The Score for VKTX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KBCSY Stock Price Chart

What is KBC Groupe NV's stock price today?

  • The KBC Groupe NV share price today is $35.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KBCSY is experiencing buying pressure, which is a positive indicator for future bullish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $52.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing slight selling pressure.

KBCSY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.62 Sell
Relative Strength Index (14 RSI): 44.1 Sell
Chaikin Money Flow: 29179 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.29 - 37.21) Sell
Bollinger Bands (100): (34.17 - 37.87) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.67 Sell
Relative Strength Index (14 RSI): 31.29 Sell
Chaikin Money Flow: -100679 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (54.48 - 68.5) Sell
Bollinger Bands (100): (41.94 - 80.24) Sell

KBCSY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.15 Buy
20-day SMA: 35.99 Sell
50-day SMA: 36.82 Sell
200-day SMA: 33.2 Buy
8-day EMA: 35.16 Buy
20-day EMA: 35.83 Sell
50-day EMA: 36.3 Sell
200-day EMA: 34.62 Buy

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.59 Sell
20-day SMA: 58.92 Sell
50-day SMA: 66.79 Sell
200-day SMA: 37.75 Buy
8-day EMA: 53.96 Sell
20-day EMA: 58.63 Sell
50-day EMA: 62.68 Sell
200-day EMA: 45.29 Buy

KBC Groupe NV Earnings Growth & KBCSY Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.06 per share, and a decrease next year of $0.00 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.44 per share.

KBC Groupe NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):